Skip to main content

Table 2 Human studies on follicle size and IVF outcomes

From: A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome?

 

Study design

Age

COH

IVF/ICSI

Oocytes

Size mm

% MII

% fert

% cleavage

% good quality embryo

Wittmack 1994 [13]

R

23-49

Long

Only IVF

6879

12-15-18-20-21-23-24

Worst recovery rate under 12 mm and over 24 mm

Increasing from 12 mm onwards

Increasing from 12 mm onwards

None

Inaudi 1995 [24]

R

28-37

Short

Only IVF

179

16-22

None in the recovery rate

n.e.

n.e.

n.e.

Dubey 1995 [26]

R

n.e.

Long

Only IVF

2429

14-16-22

n.e.

Increasing from 16 mm onwards

n.e.

n.e.

Ectors 1997 [17]

P

n.e.

Short

IVF/ICSI

2324

16-23

IVF: n.e.

IVF: increasing from 16 to 23 mm, later decreasing

IVF: increasing from 16 to 23 mm, later decreasing

IVF: increasing from 16 to 23 mm, later decreasing

       

ICSI: increasing from 16 mm onwards

ICSI: none

ICSI: none

ICSI: increasing from 16 mm onwards

Bergh 1998 [18]

P

33.0

Long

IVF/ICSI

4159

16

n.e.

IVF: increasing

IVF: none

n.e. but increasing pregnancy rate only in IVF

ICSI: none

ICSI: none

Teisser 2000 [22]

P

28.0

Long

Only IVF

150

14

Increasing

n.e.

Increasing

n.e.

Triwitayakorn 2003 [14]

P

35.9

Long short

Only ICSI

991

10-14

Always increasing together with oocyte recovery rate

None

n.e.

none

Rosen 2008 [19]

P

34.1

Long shortantag

IVF/ICSI

2934

10-13-16-19

IVF: n.e.

IVF: always increasing

n.e.

IVF: always increasing

ICSI: always increasing

ICSI: always increasing

 

ICSI: always increasing

Lee 2010 [23]

P

33.5

Long

Only ICSI

819

18-20

Increasing from 18 mm onwards

None

None

none

Mehri 2013 [20]

P

n.e.

Long

IVF/ICSI

360

15-18

Increasing from 18 mm onwards

Increasing from 18 mm onwards

None

none

  1. Only results statistically significant are reported (p < 0.05); all results are referred to size classes reported.
  2. n.e. = outcome not evaluated.
  3. none = any significant difference among size classes.
  4. always increasing = increasing from each size class onwards.
  5. COH = controlled ovarian hyperstimulation protocol (short = short GnRH analogue, otherwise known as “flare up”; long = long GnRH analogue; antag = GnRH antagonist).